Jo-Anne H. Young
#110,624
Most Influential Person Now
American physician
Jo-Anne H. Young's AcademicInfluence.com Rankings
Jo-Anne H. Youngphilosophy Degrees
Philosophy
#12002
World Rank
#16602
Historical Rank
Ontology
#166
World Rank
#194
Historical Rank
Logic
#8818
World Rank
#11084
Historical Rank
Download Badge
Philosophy
Why Is Jo-Anne H. Young Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jo-Anne H. Young is an American physician, scientist, and Editor-in-Chief of Clinical Microbiology Reviews, published by the American Society for Microbiology. Her expertise is in the areas of transplantation, infectious diseases, infections of the immune compromised host, and clinical mycology and virology.
Jo-Anne H. Young's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. (2011) (2247)
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (1683)
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective (2009) (1417)
- Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (2011) (871)
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. (2016) (467)
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. (2011) (307)
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (257)
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. (2008) (227)
- A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. (2009) (201)
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. (2014) (156)
- Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. (2015) (156)
- Histoplasmosis after solid organ transplant. (2013) (145)
- Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. (2012) (117)
- Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. (2016) (104)
- Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. (2010) (88)
- Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? (2011) (85)
- Alternative donor hematopoietic cell transplantation for Fanconi anemia. (2015) (81)
- Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. (2021) (79)
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study (2017) (74)
- Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. (2010) (71)
- An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients. (2011) (69)
- Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time. (2012) (64)
- Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. (2016) (64)
- Identification of pathogenic fungi. (2014) (63)
- Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. (2009) (54)
- Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness (2020) (51)
- A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation. (2013) (50)
- Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance. (2013) (46)
- BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (2018) (35)
- The impact of cytomegalovirus infection ≥1 year after primary renal transplantation (2010) (34)
- Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype. (2010) (34)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. (2017) (33)
- Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases (2011) (31)
- Aspergillus Infections. (2021) (31)
- Time trends in fungal infections as a cause of death in hematopoietic stem cell transplant recipients: an autopsy study. (2009) (29)
- Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study. (2019) (23)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (23)
- Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT). (2019) (21)
- Infectious complications of acute and chronic GVHD. (2008) (20)
- Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis (2015) (20)
- Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. (2019) (20)
- Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota (2017) (17)
- Epidemiology and management of infectious complications of contemporary management of chronic leukemias. (2011) (15)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (14)
- Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation. (2018) (14)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (13)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (12)
- Infections in Recipients of Hematopoietic Cell Transplantation (2010) (11)
- Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes. (2021) (9)
- Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection (2015) (8)
- Management of Infectious Diseases in Stem Cell Transplantation and Hematologic Malignancy. (2019) (7)
- Dasatinib-induced immunosuppression and recurrent respiratory tract infections (2015) (7)
- A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key (2021) (6)
- Decreased Infections in Recipients of Unrelated Donor (URD Hematopoietic Cell Transplantation (HCT) from Donors with An Activating KIR B Genotype (B/x) (2008) (6)
- Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients (2021) (5)
- Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation. (2020) (5)
- Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional registry study (2021) (4)
- Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation (2019) (4)
- Acknowledgment of Reviewers (1980) (4)
- Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia. (2012) (4)
- Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab (2013) (4)
- One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster Virus (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic Cell Transplant (HCT) Recipients (2013) (4)
- More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors (2015) (4)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (4)
- Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction (2013) (4)
- Infections in Recipients of Hematopoietic Stem Cell Transplants (2014) (3)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (3)
- Typical and Atypical Mycobacterium Infections After Hematopoietic Stem Cell or Solid Organ Transplantation (2016) (3)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (3)
- Epidemiology and Management of Infectious Complications of Contemporary Management of Chronic Leukemias. (2010) (3)
- In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia (1992) (3)
- Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination (2021) (2)
- Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation. (2022) (2)
- Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective? (2022) (2)
- Mixed vs full donor engraftment early after hematopoietic cell transplant: Impact on incidence and control of cytomegalovirus infection (2019) (2)
- Brincidofovir (CMX001) Experience in Renal Transplant Patients for Treatment of Refractory CMV Infection.: Abstract# D2364 (2014) (2)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- Prophylaxis for Aspergillosis (2009) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- Evaluation and Management of Bacterial and Fungal Infections in Patients with a Hematological Malignancy: A 2018 Update (2018) (1)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- LB-3Preliminary Safety Results and Antiviral Activity from the Open-label Pilot Portion of a Phase 3 Study to Evaluate Brincidofovir (BCV) for the Treatment of Adenovirus (AdV) Infection (2014) (1)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study (2021) (1)
- Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report (2021) (1)
- 1016. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) With Fever and Neutropenia (FN): Predictors for Morbidity and Mortality (2018) (0)
- Contributors (2015) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Acknowledgment of Reviewers (2016) (0)
- Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients (2020) (0)
- Acknowledgment of Reviewers (1979) (0)
- Steroid sensitive acute GVHD, but not steroid dependent or steroid resistant, results in similar infection risk as no GVHD following allogeneic hematopoietic cell transplantation. (2022) (0)
- Clostridium difficile Infection Among Allogeneic Hematopoietic Stem Cell and Solid Organ Transplant Recipients: Differences in Rates and Outcomes (2016) (0)
- The first case in the world of HOPE Act simultaneous liver kidney transplantation (Funding acknowledgement: Planning grant: 1r34ai23023-1; Liver U01: U01ai138897) (2020) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- (617) - REMOVED: (617) – Candida Colonization Is Associated with Improved Survival After Lung Transplant (2017) (0)
- Both "small ball" and "big inning" teams are progressing the value of antifungal prophylaxis among hematologic malignancy patients. (2020) (0)
- Acknowledgment to Reviewers (2004) (0)
- Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study (2022) (0)
- AMB or Echinocandin-Based Approaches (2009) (0)
- 1585. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) with Fever and Neutropenia (FN): Correlation Between Initial Empiric Antibiotic Regimen Correlation and Susceptibility Patterns (2018) (0)
- 2021 Acknowledgment of CMR Reviewers (2021) (0)
- Adenoviruses—Approaches to Diagnosis and Management 2016 (2016) (0)
- Similar Invasive Fungal Infection Rates and Survival after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Bone Marrow or Peripheral Blood Graft Sources (2016) (0)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (0)
- Acknowledgment of Reviewers (2001) (0)
- SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study (2023) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Final Clinical Outcomes from a Phase 2 Trial of Posoleucel, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Prevention of Clinically Significant Viral Infections Post-HCT (2022) (0)
- Acknowledgment of Reviewers (2017) (0)
- 2482. Impact of a Recombinant Zoster Vaccine on Quality of Life: Data from a Randomized, Placebo-Controlled, Phase 3 Trial in Adult Hematopoietic Stem Cell Transplant Recipients (2018) (0)
- 2670. Clostridioides difficile Infection (CDI) in Solid-Organ (SOT) and Hematopoietic Stem Cell Transplant (HCT) Recipients: A Prospective Multinational Study (2019) (0)
- Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes. (2023) (0)
- Impact of Early Bloodstream Infection (BSI) By Vancomycin-Resistant Enterococci (VRE) on Long-Term Transplant Outcomes (2017) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- 2686. strong>Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) with Fever and Neutropenia (FN): Viridans Group Streptococcus Emerges as an Important Pathogen (2019) (0)
- Mixed Versus Full Donor Engraftment Early after Allogeneic Stem Cell Transplant: The Impact on Incidence and Control of Cytomegalovirus Reactivation (2017) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- New drugs for fungal prophylaxis in transplant recipients (2004) (0)
- Aspergillus Infections. Reply. (2022) (0)
- Favorable Outcomes in Patients with Pre-Transplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (2018) (0)
- Clinical Application of Cell-Free Next Generation Sequencing for Infections after Allogeneic Hematopoietic Cell Transplantation in Pediatric and Adult Patients: a Single Center Experience (2023) (0)
- Favorable Outcome in Patients with Pre-Transplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (2017) (0)
- Acknowledgment of Reviewers (2019) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- 429Diagnosis and Treatment of Respiratory Syncytial Virus in Immunocompromised Hosts in Large Midwestern Transplant Centers (2014) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Acknowledgment of Reviewers (2018) (0)
This paper list is powered by the following services:
Other Resources About Jo-Anne H. Young
What Schools Are Affiliated With Jo-Anne H. Young?
Jo-Anne H. Young is affiliated with the following schools:
